Home / TAK-675-4011
TAK-675-4011
Recruitment Complete

Early Detection of Fabry Disease

Clinicaltrials.gov
#NCT05106764
|
Other
#FLAGGING FD-1

About this clinical trial

The main aim of this study is early detection of FD using real-world data for the development of advanced natural language processing methods and to develop a predictive algorithm and to measure the performance of the algorithm in identifying participants with FD. This study is about using data from hospital Electronic Health Record database from the last 10 years to describe the ranking of participants with FD using multilevel likelihood ratios and to validate the algorithm using positive controls. No investigational medicinal product or device will be tested in this study. Hospital electronic health record data will be analyzed for a period of up to 6 months.

DE
Observational clinical trial.

At a glance

What medical conditions were being studied?

Fabry Disease

What was the clinical trial testing?

No intervention

How many participants were enrolled?

50

Were placebos part of the clinical trial?

No

When was the clinical trial conducted?

Nov 2023 - Apr 2024

How long was participation in the clinical trial?

Participants will be in the study for about 12 months.

Key requirements

Sex

All

Age

All

Healthy volunteers?

No

Entry criteria

Must be in-patients of the participating hospital in the last 10 years
Patients of all ages can take part in this study
For part B, up to 50 patients with a high likelihood of having Fabry Disease will be contacted by the doctor and asked to participate in the diagnostic part of the study.

Locations